Prevention of Neutropenia After Using G-CSF With TAC Chemotherapy
Status:
Unknown status
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
After resection of lymph node positive breast cancer, the injection duration and timing of
Granulocyte-colony stimulating factor (G-CSF) could affect the neutropenia with TAC
(Taxotere, Adriamycin, cyclophosphamide) chemotherapy.